Fluorescence-guided bone resection by using Visually Enhanced Lesion Scope in diffuse chronic sclerosingosteomyelitis of the mandible: clinical and pathological evaluation
Mostra el registre complet de l'element
Visualització
(2.252Mb)
|
|
|
|
|
|
Yoshiga, Daigo; Sasaguri, Masaaki; Matsuo, Kou; Yoshida, Sei; Uehara, Masataka; Habu, Manabu; Haraguchi, Kazuya; Tanaka, Tatsurou; Morimoto, Yasuhiro; Yoshioka, Izumi; Tominaga, Kazuhiro
|
|
Aquest document és un/a article, creat/da en: 2015
|
|
|
|
Diffuse chronic sclerosingosteomyelitis (DCSO) is a refractory disease, becausethe etiology and pathogenesis remain poorly understood and to determine the border betweenunhealthy boneandhealthybone is difficult. However,
progressive inflammation, clinical symptoms and a high recurrence rate of DCSO were the reasons for surgical
treatment. We report a case of a 66-year old woman with DCSO of the right side of mandible who was treated with
hemimandibulectomy and simultaneous reconstruction by vascularized free fibula flap. After preoperative administration of minocycline for 1 month, the bone fluorescence was successfully monitored by using a Visually Enhanced Lesion Scope (VELscope®). Intraoperatively, we could determine the resection boundaries. We investigated
the clinical and histopathological findings. The fluorescence findings were well correlated with histopathological
findings. Using a VELscope®was handy and useful to determine the border between DCSO lesion andhealthybone.
The free fibula flap under the minocycline-derived bone fluorescence by using a VELscope®offered a good quality
of mandibular bone and the successful management of an advanced and refractory DCSO.
|
|
Veure al catàleg Trobes
|
Aquest element apareix en la col·lecció o col·leccions següent(s)
Mostra el registre complet de l'element